Ribonucleotide reductase potential inhibitors: Design, synthesis and activity of bioisosters of ribofuranosylnucleoside diphosphates.

被引：0
|
作者：
Manfredini, S
Augusti, A
Durini, E
Vertuani, S
Nalin, F
Verri, A
Spadari, S
Focher, F
Solaroli, N
De Clercq, E
Balzarini, J
Ferrone, M
Pricl, S
机构：
[1] Univ Ferrara, Dept Pharmaceut Sci, I-44100 Ferrara, Italy
[2] CNR, Ist Genet Biochim & Evoluzionist, I-00185 Rome, Italy
[3] Huddinge Univ Hosp, Div Clin Virol, Huddinge, Sweden
[4] Katholieke Univ Leuven, Rega Inst Med Res, Louvain, Belgium
[5] Univ Trieste, Dept Chem Engn, I-34127 Trieste, Italy
来源：
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY | 2002年 / 224卷
关键词：
D O I：
暂无
中图分类号：
O6 [化学];
学科分类号：
0703 ;
摘要：
038-MEDI
引用
收藏
页码：U11 / U11
页数：1
相关论文
共 50 条
  • [21] NEW RIBONUCLEOTIDE REDUCTASE INHIBITORS POSSESSING ANTI-TUMOR ACTIVITY
    ELFORD, HL
    RIET, BV
    WAMPLER, G
    ROBERTSON, RH
    ELFORD, RM
    MEDICAL AND PEDIATRIC ONCOLOGY, 1982, 10 (01): : 102 - 102
  • [22] ENHANCEMENT BY DEFEROXAMINE OF INHIBITION OF DNA-SYNTHESIS BY RIBONUCLEOTIDE REDUCTASE INHIBITORS
    BROCKMAN, RW
    ADAMSON, D
    STRINGER, V
    SHADDIX, S
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1972, 13 (MAR): : 88 - &
  • [23] Synthesis and biological activity of a bivalent nucleotide inhibitor of ribonucleotide reductase
    Wu, X
    Cooperman, BS
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2000, 10 (20) : 2387 - 2389
  • [24] The potential of novel ribonucleotide reductase inhibitors, Didox and Trimidox, compared to hydroxyurea to enhance NRTI antiviral activity in vivo
    Sumpter, R
    Elford, H
    Inayat, M
    Sugg, T
    Tsai, P
    Gallicchio, V
    ANTIVIRAL RESEARCH, 2003, 57 (03) : A48 - A48
  • [25] CHANGES IN MAMMALIAN RIBONUCLEOTIDE REDUCTASE ACTIVITY - DENOVO ENZYME SYNTHESIS
    ELFORD, HL
    FEDERATION PROCEEDINGS, 1971, 30 (03) : 1229 - &
  • [26] The potential of novel ribonucleotide reductase inhibitors, Didox and Trimidox, to reduce doxorubicin cardiotoxicity and enhance antitumor activity.
    Elford, HL
    Cardounel, AJ
    Mikhail, E
    Szekeres, T
    Zweier, JL
    CLINICAL CANCER RESEARCH, 2001, 7 (11) : 3749S - 3749S
  • [27] Structure-guided design of anti-cancer ribonucleotide reductase inhibitors
    Misko, Tessianna A.
    Liu, Yi-Ting
    Harris, Michael E.
    Oleinick, Nancy L.
    Pink, John
    Lee, Hsueh-Yun
    Dealwis, Chris G.
    JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY, 2019, 34 (01) : 438 - 450
  • [28] Design, synthesis, antiproliferative activity, and cell cycle analysis of new thiosemicarbazone derivatives targeting ribonucleotide reductase
    Ahmed, Marwa F.
    Almalki, Atiah H.
    ARABIAN JOURNAL OF CHEMISTRY, 2021, 14 (03)
  • [29] Computational Analysis of the Apoptotic Activity of a Small Library of Novel Substituted Hydroxy Ureas Designed as Potential Inhibitors of Ribonucleotide Reductase
    McCourt, Mary P.
    Greene, Robert S.
    Smith, Charles
    McClory, Haley
    Wirth, Christopher
    Sumbler, Brittany
    Emery, Michelle L.
    Leskiw, Brian D.
    Krause, Josef G.
    McGahan, Megan E.
    Vanio, Shawn
    Jordan, Michael
    Pericozzi, Angela
    Priefer, Ronny
    LETTERS IN DRUG DESIGN & DISCOVERY, 2011, 8 (07) : 580 - 584
  • [30] The potential of novel ribonucleotide reductase inhibitors, Didox and Trimidox, compared to hydroxyurea to enhance abacavir antiviral activity in vivo.
    Elford, H
    Sumpter, R
    Inayat, M
    Gallicchio, V
    ANTIVIRAL RESEARCH, 2002, 53 (03) : A46 - A46
12345